Tasaki, Y., Sugiyama, Y., Hamamoto, S., Naiki, T., Uemura, T., Yokota, K., . . . Furukawa‐Hibi, Y. (2023). Eosinophil may be a predictor of immune‐related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study. Wiley.
Chicago Style (17th ed.) CitationTasaki, Yoshihiko, et al. Eosinophil May Be a Predictor of Immune‐related Adverse Events Induced by Different Immune Checkpoint Inhibitor Types: A Retrospective Multidisciplinary Study. Wiley, 2023.
MLA (9th ed.) CitationTasaki, Yoshihiko, et al. Eosinophil May Be a Predictor of Immune‐related Adverse Events Induced by Different Immune Checkpoint Inhibitor Types: A Retrospective Multidisciplinary Study. Wiley, 2023.
Warning: These citations may not always be 100% accurate.